As per SNS Insider Research, The DNA Manufacturing Market growth is driven by plasmid DNA demand, biopharma innovation, and advancements in DNA-based vaccine production.Austin, Nov. 07, 2025 (GLOBE ...
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the first ...
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
A new study exploring the structure of a tardigrade’s DNA damage-supressor protein could unlock a pathway to new levels of ...
A novel gene supplementation method shows promise for treating genetic infertilityFor many couples facing infertility, ...
To fix KJ's specific mutation, scientists developed a customized gene therapy consisting of a guide and an mRNA that carried ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies Dr. Adrian ...
Biopharmaceuticals: Redefining the Future of Modern MedicineThe Global Bio Pharmaceuticals Market is valued at USD 421.58 ...
Despite showing no meaningful benefit on lung function, Arcturus’ mRNA therapy ARCT-032 reduced mucus volume in patients with cystic fibrosis—an outcome William Blair found "potentially promising." ...
Our round-up of biotech financings is led this week by Braveheart Bio, a San Francisco biotech that has launched with $185 ...
FUJIFILM Corporation today announced that it has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national institution recognized for its leadership in cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results